Clinical Trials Administrator Archives – August 1, 2004
August 1, 2004
View Issues
-
When do you really need to use a data safety monitoring board?
More clinical trials are using data safety monitoring boards (DSMBs) in recent years as investigators, sponsors, and clinical trials managers increasingly see the value of added checks and balances to subject protection, experts say. -
The downside of the diversity drive
At many professional meetings and workshops, clinical trial investigators and coordinators crowd into presentations offering advice on recruiting and retaining women and minority subjects. -
NIH announces new outside work restrictions
In the wake of congressional hearings levying conflict of interest allegations at top scientists at the NIH, the director, Elias Zerhouni, has announced new restrictions on the types of paid consulting agreements federal scientists can accept with pharmaceutical and biotechnology companies. -
CAM studies should meet research standards
While interest in complementary and alternative medicine (CAM) research increases in the United States, there remain some significant challenges to properly designing these studies, an expert states. -
Demand-driven research yields greater benefits
Current health care research and service development all too often misses the target, according to presenters during the Translating Research Into Practice: Advancing Excellence from Discovery to Delivery, conference held in Washington, DC, in July. -
News Brief
AMA wants all clinical trial results in database